PrimaPharma, Inc.

primapharma.net

PrimaPharma is a Contract Development and Manufacturing Organization ("CDMO") manufacturing prescription and over-the-counter drugs, medical devices, and clinical trial materials. Established in 1992, the Company is ISO 13485 certified, and its facility is routinely inspected by the FDA. PrimaPharma's core competencies include aseptic fill and finish of injectables and ophthalmics. In 2016, PrimaPharma will be adding Blow Fill Seal production technology and automated syringe and vial filling to its service offerings.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

MEDIPHARM LABS ENTERS INTO $6.2M PURCHASE AGREEMENT FOR THE SALE OF AUSTRALIAN FACILITY

MediPharm Labs Corp. | July 12, 2022

news image

MediPharm Labs Corp. a pharmaceutical company specialized in precision-based cannabinoids, has entered into a Share Purchase Agreement with OneLife Botanicals PTY for the sale of MediPharm Labs Australia Pty Ltd a wholly-owned subsidiary of the Company, for a minimum value of $6.9M AUD. The Agreement is subject to routine conditions and is anticipated to close within 90 days. The Agreement includes the assets of MPLA, specialized licensing, operational knowledge, and Austral...

Read More

VIEWS AND ANALYSIS, PHARMACY MARKET

VINCERX PHARMA PRESENTS PRECLINICAL DATA ON VIP943 IN ACUTE MYELOID LEUKEMIA MODELS AT THE 64TH AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING 2022

Vincerx Pharma, Inc. | December 12, 2022

news image

Vincerx Pharma, Inc. a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced a poster presentation of preclinical data of Vincerx’s proprietary payload and linker technology and VIP943, the Company’s internalizing ADC targeting CD123, at the 64th American Society of Hematology Annual Meeting 2022. VIP943 is a novel ADC, which binds to the IL3-receptor alpha chain . VIP943 co...

Read More

Business Insights, PHARMACY MARKET

PATSNAP UNVEILS SYNAPSE VISITOR, THE LATEST AI-POWERED PHARMACEUTICAL INTELLIGENCE PLATFORM

Prnewswire | April 25, 2023

news image

On April 20, Patsnap, the world's leading SaaS provider for intelligence, announced the launch of its latest version of the intelligence platform, Synapse, available to visitors. This version includes advanced search functions for drugs and pharmaceutical organizations, now publicly accessible for the first time. Users can explore these features without prior registration, making searching easier and more accessible than ever before. Synapse is an innovative Life Sciences Pl...

Read More

Pharma Tech

PACE® LIFE SCIENCES ACQUIRES BIOPHARMA GLOBAL, EXPANDING FDA REGULATORY AFFAIRS STRATEGY AND CONSULTING CAPABILITIES

Pace® Life Sciences | September 09, 2022

news image

Pace® Life Sciences, LLC, a full-service contract development and manufacturing organization and a subsidiary of Pace®, a science and technology company, announced today that it has acquired Biopharma Global. Biopharma specializes in full-service regulatory support for orphan products to treat rare diseases and non-orphan products to treat indications with unmet medical needs. "Pace® provides great value in our marketplace through our technic...

Read More
news image

Business Insights

MEDIPHARM LABS ENTERS INTO $6.2M PURCHASE AGREEMENT FOR THE SALE OF AUSTRALIAN FACILITY

MediPharm Labs Corp. | July 12, 2022

MediPharm Labs Corp. a pharmaceutical company specialized in precision-based cannabinoids, has entered into a Share Purchase Agreement with OneLife Botanicals PTY for the sale of MediPharm Labs Australia Pty Ltd a wholly-owned subsidiary of the Company, for a minimum value of $6.9M AUD. The Agreement is subject to routine conditions and is anticipated to close within 90 days. The Agreement includes the assets of MPLA, specialized licensing, operational knowledge, and Austral...

Read More
news image

VIEWS AND ANALYSIS, PHARMACY MARKET

VINCERX PHARMA PRESENTS PRECLINICAL DATA ON VIP943 IN ACUTE MYELOID LEUKEMIA MODELS AT THE 64TH AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING 2022

Vincerx Pharma, Inc. | December 12, 2022

Vincerx Pharma, Inc. a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced a poster presentation of preclinical data of Vincerx’s proprietary payload and linker technology and VIP943, the Company’s internalizing ADC targeting CD123, at the 64th American Society of Hematology Annual Meeting 2022. VIP943 is a novel ADC, which binds to the IL3-receptor alpha chain . VIP943 co...

Read More
news image

Business Insights, PHARMACY MARKET

PATSNAP UNVEILS SYNAPSE VISITOR, THE LATEST AI-POWERED PHARMACEUTICAL INTELLIGENCE PLATFORM

Prnewswire | April 25, 2023

On April 20, Patsnap, the world's leading SaaS provider for intelligence, announced the launch of its latest version of the intelligence platform, Synapse, available to visitors. This version includes advanced search functions for drugs and pharmaceutical organizations, now publicly accessible for the first time. Users can explore these features without prior registration, making searching easier and more accessible than ever before. Synapse is an innovative Life Sciences Pl...

Read More
news image

Pharma Tech

PACE® LIFE SCIENCES ACQUIRES BIOPHARMA GLOBAL, EXPANDING FDA REGULATORY AFFAIRS STRATEGY AND CONSULTING CAPABILITIES

Pace® Life Sciences | September 09, 2022

Pace® Life Sciences, LLC, a full-service contract development and manufacturing organization and a subsidiary of Pace®, a science and technology company, announced today that it has acquired Biopharma Global. Biopharma specializes in full-service regulatory support for orphan products to treat rare diseases and non-orphan products to treat indications with unmet medical needs. "Pace® provides great value in our marketplace through our technic...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us